开年第一会，聚力抓质量｜南模生物“2026质量管理年”全面启动
为加速迈向国际一流企业的战略目标，南模生物于2026年2月24日正式召开“2026年质量管理年”启动会，全面部署以卓越质量体系推动公司全球竞争力提升的年度行动。会议由副总经理孙瑞林主持，董事长费俭、总经理张春明出席会议并作动员讲话。
会议指出，质量是公司走向世界一流的核心竞争力，必须将卓越质量意识融入企业文化和日常运营的每一个环节。公司号召全体员工主动提升质量素养，将高标准、严要求切实贯彻到研发、生产、服务等全业务流程中，以持续优化的质量管理体系支撑公司长远发展与国际化布局。
各部门负责人全程参会，深入研讨质量提升路径。新年伊始，此次启动会明确了全年工作的关键主题：以质量引领发展，以规范保障落实。南模生物将持续强化全员参与、全过程管控的质量建设机制，通过严格执行国际标准与行业规范，为公司实现可持续、高质量发展奠定坚实基础。
你也可能感兴趣
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
